Adia Nutrition (ADIA) Net Cash Flow Growth (1y) (2026)
Powered by 
Analysis
Adia Nutrition (ADIA) Net Cash Flow Growth (1y) (2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 9.96 Bn | 9.12 Bn | 112.79 Mn | -263.05% |
| 2 | CRISPR Therapeutics AG | 5.47 Bn | 5.47 Bn | - | - |
| 3 | Iovance Biotherapeutics | 4.64 Bn | 4.35 Bn | 55.72 Mn | -111.96% |
| 4 | Legend Biotech | 3.25 Bn | 2.28 Bn | 251.50 Mn | 114.92% |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | - |
| 6 | Precigen | 2.79 Bn | 2.79 Bn | 52.17 Mn | - |
| 7 | Beam Therapeutics | 2.58 Bn | 2.58 Bn | - | - |
| 8 | Sarepta Therapeutics | 2.12 Bn | 1.33 Bn | 251.87 Mn | -61.56% |
| 9 | Vericel | 2.05 Bn | 1.89 Bn | 56.40 Mn | 1,842.32% |
| 10 | Adia Nutrition | 11.33 Mn | 11.33 Mn | - | - |